Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

This is a list of beneficial owners of Nanoviricides. Leo and Menon used to be big deals there. Scroll down to the bolded parts. Leo clearly has no issue helping out his family at the expense of the shareholder. This to me is more a case of croynism then any back rooom deal with the MFO. Unless...there is more to be revealed.

Once more, I can't take credit for this "middle school" research.

See page 49.


https://content.edgar-online.com/ExternalLink/EDGAR/0001144204-06-047712.html?hash=43bd37141095faae8da7279c3e40fa5c6ece0bd9189b5e6f546c73462a1b527d&dest=V057372_EX4-1_HTM#V057372_EX4-1_HTM


Name and Address of Beneficial Owner

Amount and Nature of Beneficial Owner

Percent of Class

Total Business Services, Inc.

5,834,000

5.19
%
Chloe Flynn (1)

1,500,000

1.33
%
Conor Flynn (2)

1,500,000

1.33
%
Theracour Pharma, Inc.(*)

35,370,000

31.46
%
Anil Diwan (3) (*)

10,000,000

9.70
%
Eugene Seymour (4) (*)

8,500,000

7.97
%
Leo Ehrlich (5) (*)

5,850,000

5.62
%
Helene Ehrlich (6) (*)

1,500,000

1.33
%
Barrett Ehrlich (6) (*)

500,000

0.44
%
Elliot Ehrlich (6) (*)

500,000

0.44
%
Joshua Ehrlich (6) (*)

500,000

0.44
%
Sarah Ehrlich (6) (*)

500,000

0.44
%
Krishna Menon

1,500,000

1.33
%
Jayant Tatake

1,200,000

1.07
%
Randall Barton (7)

250,000

0.26
%
Paul Marks (8)

100,000

0.12
%
Cy Stein (9)

75,000

0.10
%
Harmon Aronson (10)

250,000

0.26
%
John Rossi (11)

50,000

0.08
%
All Directors and Executive Officers as a Group (*)

63,220,000

57.84
%


49

(*)
Directors , Executive Officers, their families, and TheraCour Pharma, of which Messrs. Diwan and Ehrlich have voting control.


(1)
Chloe Flynn is the daughter of John Flynn, the sole shareholder and officer of Total Business Services, Inc.


(2)
Conor Flynn is the son of John Flynn, the sole shareholder and officer of Total Business Services, Inc.


(3)
Anil Diwan owns options to acquire an additional 1,000,000 shares of the Company’s Common Stock and 65% of the voting stock of TheraCour Pharma, Inc.


(4)
Eugene Seymour owns options to acquire an additional 500,000 shares of the Company’s Common Stock


(5)
Leo Ehrlich owns options to acquire an additional 500,000 shares of the Company’s Common Stock and 10% of the voting stock of Theracour Pharma, Inc.


(6)
The wife and children of Leo Ehrlich, the Company’s Chief Financial Officer.